Summarized by Masters of Longevity from Fight Aging!.
Anti-CXCR3 research: a concise news-style summary describing a preclinical study about preventing immune cell entry into the brain and its potential therapeutic implications.
Key Takeaways
- Antibody blockade or genetic deletion of CXCR3 or CXCL10 prevented IFNγ‑driven brain T cell infiltration in an acute hippocampal model.
- Chronic systemic anti‑CXCR3 treatment reduced parenchymal CD4+ and CD8+ T cell accumulation and attenuated neurodegeneration in a tauopathy mouse model.
- CXCR3 blockade lowered microglial MHC‑II expression and shifted brain T cells toward reduced activation and greater CD8+ terminal exhaustion.
